GODIVA GROUP PRACTICE
5 CLAY LANE, COVENTRY
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 4 | 6 | 66.7% | |
| HF 4 | 2011 | 11 | 11 | 100.0% | |
| HF 4 | 2012 | 8 | 8 | 100.0% | |
| HF 4 | 2013 | 9 | 9 | 100.0% | |
| HF004 | 2014 | 5 | 5 | 100.0% | |
| HF004 | 2015 | 6 | 6 | 100.0% | |
| HF004 | 2016 | 7 | 7 | 100.0% | |
| HF004 | 2017 | 5 | 5 | 100.0% | |
| HF004 | 2018 | 20 | 20 | 100.0% | |
| HF004 | 2019 | 18 | 20 | 90.0% | |
| HF004 | 2020 | 26 | 29 | 89.7% | |
| HF006 | 2021 | 32 | 34 | 94.1% | |
| HF006 | 2022 | 56 | 58 | 96.6% | |
| HF006 | 2023 | 59 | 60 | 98.3% |
